Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA.
Mutants of adenovirus type 5 (Ad5) virus-associated RNA I deficient in inhibiting the activation and subsequent phosphorylation of protein kinase R (PKR) could neither function as helpers for adeno-associated virus type 5 (AAV5) replication nor enhance AAV5 protein accumulation in either the presence or absence of Ad5 E4Orf6 and E2a. Furthermore, a short region of the AAV5 capsid gene RNA leader sequence surrounding the AUG of VP1 could induce the phosphorylation of eIF2alpha. Both short interfering RNA directed against PKR and the addition of the herpes simplex virus ICP34.5 protein enhanced the accumulation of AAV5 capsid protein in the presence of the AAV5 capsid gene PKR-inducing element, suggesting that VA RNA acted to overcome direct AAV5-induced activation of PKR that led to the phosphorylation of eIF2alpha. The expression of both the closely related goat-derived AAV and the prototype AAV2 capsid gene transcription units also induced the phosphorylation of eIF2alpha, suggesting that the induction of the PKR/eIF2alpha cellular response may be a previously unrecognized general feature of at least the Dependovirus genus of the Parvovirinae.
Nayak
Ramnath
R
Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri-Columbia, 1201 Rollins Road, Columbia, MO 65211, USA.
Pintel
David J
DJ
D000256:Adenoviridae / Q000378:metabolism*; D002213:Capsid / Q000378:metabolism; D000229:Dependovirus / Q000235:genetics / Q000378:metabolism*; D004789:Enzyme Activation; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism*; D015967:Gene Expression Regulation, Viral; D006367:HeLa Cells; D006801:Humans; D008957:Models, Genetic; D010766:Phosphorylation; D034741:RNA, Small Interfering / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism*; D014764:Viral Proteins / Q000737:chemistry; D019892:eIF-2 Kinase / Q000378:metabolism*
D015852:Eukaryotic Initiation Factor-2; D034741:RNA, Small Interfering; D012367:RNA, Viral; D014764:Viral Proteins; C066469:gamma 34.5 protein, Human herpesvirus 1; D019892:eIF-2 Kinase
Virology. 1989 Feb;168(2):320-9
2536986
J Virol. 2007 Mar;81(5):2205-12
17166904
J Virol. 1991 Nov;65(11):5657-62
1920611
J Virol. 1993 Jun;67(6):3534-43
8098780
J Virol. 1995 Jul;69(7):4299-307
7769691
Curr Top Microbiol Immunol. 1995;199 ( Pt 2):173-87
7555067
Virology. 1995 Dec 1;214(1):222-8
8525619
Oncogene. 1999 Nov 1;18(45):6112-20
10557102
J Viral Hepat. 1999 Sep;6(5):343-56
10607250
J Biol Chem. 2001 Jul 13;276(28):25910-8
11342536
Clin Microbiol Rev. 2001 Oct;14(4):778-809, table of contents
11585785
Mol Cell Biol. 2002 Jun;22(11):3639-52
11997501
Chembiochem. 2002 Sep 2;3(9):859-65
12210987
J Virol. 2003 Apr;77(8):4626-34
12663769
J Virol. 2004 Jan;78(1):441-53
14671124
Virology. 1980 Jul 30;104(2):502-5
6249041
J Virol. 1981 Oct;40(1):241-7
6270377
J Virol. 1982 Mar;41(3):868-76
6284977
Virology. 1987 Sep;160(1):38-47
2820138
J Virol. 1988 Jan;62(1):68-74
2824856
J Virol. 1996 Jan;70(1):520-32
8523565
J Virol. 1996 May;70(5):3227-34
8627803
J Virol. 1996 Aug;70(8):5083-99
8764016
Curr Top Microbiol Immunol. 1996;218:1-23
8794242
Gene Ther. 1998 Jul;5(7):938-45
9813665
J Mol Biol. 2006 May 19;358(5):1270-85
16580685
J Virol. 2006 Jul;80(13):6559-67
16775342
Virology. 1991 Mar;181(1):22-34
1825251